These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 22130319)
1. In vivo optical coherence tomography of very late drug-eluting stent thrombosis compared with late in-stent restenosis. Miyazaki S; Hiasa Y; Takahashi T; Yano Y; Minami T; Murakami N; Mizobe M; Tobetto Y; Nakagawa T; Chen PM; Ogura R; Miyajima H; Yuba K; Hosokawa S; Kishi K; Ohtani R Circ J; 2012; 76(2):390-8. PubMed ID: 22130319 [TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation. Ko YG; Kim DM; Cho JM; Choi SY; Yoon JH; Kim JS; Kim BK; Choi D; Jang Y; Hong MK Int J Cardiovasc Imaging; 2012 Apr; 28(4):715-23. PubMed ID: 21656060 [TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining. Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of Earlier Versus Delayed Presentation of Very Late Drug-Eluting Stent Thrombosis: An Optical Coherence Tomographic Study. Lee SY; Ahn JM; Mintz GS; Hur SH; Choi SY; Kim SW; Cho JM; Hong SJ; Kim JW; Hong YJ; Lee SG; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Park SJ; Hong MK J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411245 [TBL] [Abstract][Full Text] [Related]
5. Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation. Kim BK; Kim JS; Oh C; Ko YG; Choi D; Jang Y; Hong MK Int J Cardiovasc Imaging; 2012 Apr; 28(4):705-14. PubMed ID: 21626042 [TBL] [Abstract][Full Text] [Related]
6. Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis. Nakamura D; Attizzani GF; Toma C; Sheth T; Wang W; Soud M; Aoun R; Tummala R; Leygerman M; Fares A; Mehanna E; Nishino S; Fung A; Costa MA; Bezerra HG Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582113 [TBL] [Abstract][Full Text] [Related]
8. Very long-term follow-up of strut apposition and tissue coverage with Biolimus A9 stents analyzed by optical coherence tomography. Staico R; Costa MA; Chamié D; Bezerra H; Armaganijan LV; Costa RA; Costa JR; Siqueira D; Centemero M; Chaves Á; Tanajura LF; Abizaid A; Feres F; Sousa JE; Sousa AG Int J Cardiovasc Imaging; 2013 Jun; 29(5):977-88. PubMed ID: 23456358 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography. Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418 [TBL] [Abstract][Full Text] [Related]
10. Long-term (≥2 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results. Kim TH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Int J Cardiovasc Imaging; 2011 Jul; 27(6):875-81. PubMed ID: 20978851 [TBL] [Abstract][Full Text] [Related]
11. Difference in neointimal appearance between early and late restenosis after sirolimus-eluting stent implantation assessed by optical coherence tomography. Ino Y; Kubo T; Kitabata H; Ishibashi K; Tanimoto T; Matsuo Y; Shimamura K; Shiono Y; Orii M; Komukai K; Yamano T; Yamaguchi T; Hirata K; Tanaka A; Mizukoshi M; Imanishi T; Akasaka T Coron Artery Dis; 2013 Mar; 24(2):95-101. PubMed ID: 23363984 [TBL] [Abstract][Full Text] [Related]
12. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. Guagliumi G; Sirbu V; Musumeci G; Gerber R; Biondi-Zoccai G; Ikejima H; Ladich E; Lortkipanidze N; Matiashvili A; Valsecchi O; Virmani R; Stone GW JACC Cardiovasc Interv; 2012 Jan; 5(1):12-20. PubMed ID: 22230145 [TBL] [Abstract][Full Text] [Related]
13. Causes of very late stent thrombosis investigated using optical coherence tomography. Amioka M; Shiode N; Kawase T; Kagawa Y; Yamane K; Takahashi L; Okubo Y; Tamekiyo H; Otsuka M; Okimoto T; Masaoka Y; Hayashi Y; Itakura K; Kato M; Dote K; Kihara Y; Intern Med; 2014; 53(18):2031-9. PubMed ID: 25224184 [TBL] [Abstract][Full Text] [Related]
14. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study. Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242 [TBL] [Abstract][Full Text] [Related]
15. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium). Joner M; Koppara T; Byrne RA; Castellanos MI; Lewerich J; Novotny J; Guagliumi G; Xhepa E; Adriaenssens T; Godschalk TC; Malik N; Alfonso F; Tada T; Neumann FJ; Desmet W; Ten Berg JM; Gershlick AH; Feldman LJ; Massberg S; Kastrati A; JACC Cardiovasc Interv; 2018 Jul; 11(14):1340-1350. PubMed ID: 30025727 [TBL] [Abstract][Full Text] [Related]
16. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT. Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915 [TBL] [Abstract][Full Text] [Related]
17. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up. Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536 [TBL] [Abstract][Full Text] [Related]
18. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis. Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147 [TBL] [Abstract][Full Text] [Related]
19. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography. Gonzalo N; Barlis P; Serruys PW; Garcia-Garcia HM; Onuma Y; Ligthart J; Regar E JACC Cardiovasc Interv; 2009 May; 2(5):445-52. PubMed ID: 19463469 [TBL] [Abstract][Full Text] [Related]
20. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]